Result: When the
rtL269I mutation was added to the
YMDD mutants, the relative replication levels (no drug vs LMV or ETV treatment) of none of the artificial mutants were significantly altered by LMV (Fig 3A and 3B) or ETV treatment (Fig 4A and 4B).
Discussion: Approximately 2-, 3-, 4-, and 7-fold higher replication capacity was observed when the
rtL269I mutation was introduced to WT,
rt Discussion: However, among the 16 patients in whom the YMDD mutation was detectable during antiviral treatment, 7 (43.8%) displayed the rtL269I substitution along with rtM204I/V mutation (Table 1).